In addition, SCFAs also reduces hepatic inflammation and steatosis by increasing c-Jun N-terminal kinase (JNK) and NF-κB phosphorylation, inhibiting the secretion of proinflammatory cytokines, and suppressing the activity of histone acetyltransferases to reduce the generation of regulatory T cells (96). Here, NFKB1 is linked to steatosis.